| About the author: |
R. V. Lutsenko, A. H. Sydorenko, O. O. Koiro, V. V. Tsyvunin, Yu. B. Larinovska |
| Heading |
EXPERIMENTAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
In experiments on 64 white male rats, the effect of 2-hydroxy-n-naphthalene-1-yl-2-(2-oxy-1,2-dihydro-indole-3-yliden)-acetamide (12 mg/kg) compared to ethylmethylhydroxypyridine succinate (50 mg/ml) on the course of acute kidney injury caused by glycerol and tetrachloromethane hepatitis was studied. It has been found that the use of 2-hydroxy-n-naphthalene-1-yl-2-(2-oxy-1,2-dihydro-indole-3-yliden)-acetamide against the background of tetrachloromethane hepatitis exhibits hepatoprotective properties, as evidenced by a decrease in the organ mass coefficient and the activity of enzymes-markers of damage to hepatocytes of alanine aminotransferase and aspartate aminotransferase in blood serum. The hepatoprotective effect of the studied compound is not inferior to ethylmethylhydroxypyridine succinate. In addition, a derivative of 2-oxyindoline-3-glyoxylic acid reduced the onset time of thiopental anesthesia. In acute glycerol-induced kidney injury, 2-hydroxy-n-naphthalene-1-yl-2-(2-oxy-1,2-dihydro-indole-3-yliden)-acetamide had only the antiproteinuric action and did not show sufficient protective effect. This indicates the absence of the nephroprotective effect in the substance and possible side effects from the kidneys. |
| Tags |
2-oxyindoline-3-glyoxylic acid derivative, liver, kidneys, tetrachloromethane, glycerol, rats |
| Bibliography |
- Drachuk V.M. Nefroprotektorna aktyvnist pokhidnykh sirkovmisnykh aminokyslot (ademetioninu, taurynu ta hlutationu) za umov eksperymentalnoho hostroho poshkodzhennia nyrok [dysertatsia]. Kharkiv: Natsionalnyi Farmatsevtychnyi Universytet; 2019. 25s. [in Ukrainian]
- Kamyshnykov V, Redaktor. Metody klynycheskykh laboratornykh yssledovanyi. Yzd. 10-E. Moskva: MEDpress-Ynform; 2020. 736s. [In Russian]
- Kovalenko V, Viktorova A, redaktory. Kompendyum 2018 – lekarstvennye preparaty. K.: MORYON; 2019. 2560s. [in Russian]
- Leonov V, redaktor. Nagliadnaya meditsinskaya statistika ucheb. Posobiye per. S anhl. Izd. 3-E Pererab. y dop. Moskva HEOTAR-Medya; 2015. 216s. [In Russian]
- Markina А, Mishchenko О. Skriningovye issledovaniya novykh proizvodnykh 2-oksoyndolyna. Farmakolohiya ta likarska toksykolohiya. 2017;3(54):69–73. [in Russian]
- Mironov A, redaktor. Rukovodstvo po provedenyiu doklinicheskikh issledovaniy lekarstvennykh sredstv. Moskva: Hryf y K; 2012. 944s. [In Russian]
- Razumnyi R, Spirina I. Osoblyvosti psykhichnoho statusu khvorykh na nehospitalnu pnevmoniyu, spoluchenu z khronichnoyu patolohiieyu hepatobiliarnoyi systemy nevirusnoho henezu. Medychni perspektyvy. 2017;1:68–75. [in Ukrainian]
- Redkin R, Chernykh V, Shemchuk L, Tsubanova N, Shtryhol C. Doslidzhennia zalezhnosti “khimichna struktura – antyhipoksychna diya” v riadu pokhidnykh indolu ta 2-oksindolu yaki mistiat etylaminovyi frahment. Zhurnal orhanichnoyi ta farmatsevtychnoyi khimiyi. 2014;12(1):28–38. [in Ukrainian]
- Tovchyha O, Shtryhol S, Larianovska Yu. Vplyv nastoiky yahlytsi zvychainoyi (Aegopodium podagraria l.) ta metforminu na histostrukturu ta funktsiyu nyrok shchuriv z aloksanovym diabetom. Farmakolohiya ta likarska toksykolohiya. 2018;1:45–58. [in Ukrainian]
- Chaikovska M, Martynyuk L. System inflammation and protein energy wasting correction in patients with chronic kidney disease. Ukrainian Journal of Nephrology and Dialysis. 2019; 2(62):41–47.
- Lutsenko R, Vakhnenko A, Vlasova E. Research of the protection actions of derived 2-oxoindole in acute stress. Wiadomosci Lekarskie. 2017;30(1):57–61.
- Lutsenko R, Vlasova E, Kolot E, Gladka V, Sidorenko A. The exchange of monoamines during the experimental neurosis on the background of using of amide «2-hydroxy-n-naphthalen-1-yl-2-(2-oxo-1,2-dihydroindol-3-ylidene)».Wiadomosci Lekarskie. 2017;30(5): 895–900.
- Monamy V. Animal experimentation: a guide to the issues. 3 edition. New York: Cambridge; 2017. 125 p.
- Shirazian S, Grant C, Aina O, Mattana J, Khorassani F. Ricardo A. Depression in chronic kidney disease and end-stage renal disease: similarities and differences in diagnosis, epidemiology, and management. Kidney Int Rep. 2017;2:94–107.
- Söderlund J, Lindskog M. Relevance of rodent models of depression in clinical practice: can we overcome the obstacles in translational neuropsychiatry? International Journal of Neuropsychopharmacology. 2018;7:668–676.
|
| Publication of the article |
«World of Medicine and Biology» №2(76), 2021 year, 223-226 pages, index UDK 54-32:547:615 |
| DOI |
10.26724/2079-8334-2021-2-76-223-226 |
